Leading With Data And Digital In The Life Sciences

By Remy Evard and John Reynders

Data science. Digital. AI. These seem to be the new must-have capabilities in pharma and biotech. As a leader in the industry, you are no doubt facing strategic questions about these. Is AI just hype? What does a good digital strategy look like in practice? Are you late to the game? Can an investment in data science make a high-impact difference in your business, and what should you be expecting from your data scientists?

Both of us have held leadership roles in science-based organizations for over 20 years, changing the arc of drug discovery and development through technology and data. Our experience spans CIO and CTO roles, heads of data sciences, strategy and portfolio, executive committee roles, and leadership in enterprises scaling from a pre-IPO approximately 60-person company in Cambridge (Moderna), through portfolios of biotechs (Flagship Pioneering), to the world’s largest healthcare companies (J&J and Novartis).